With
recent advances and success in several drugs designed to treat
acute and chronic diseases, targeted covalent inhibitors show a resurgence
in drug discovery. As covalent inhibition is time-dependent, the preferred
quantitative potency metric of irreversible inhibitors is the second-order
rate constant k
inact/K
i, rather than IC50. Here, we present the development
of a mass spectrometry-based platform for rapid kinetic analysis of
irreversible covalent inhibitors. Using a simple liquid handling robot
for automated sample preparation and a solid-phase extraction-based
RapidFire–MS system for rapid MS analysis, kinetic characterization
of covalent inhibitors was performed in high throughput both by intact
protein analysis and targeted multiple reaction monitoring (MRM).
In addition, a bimolecular reaction model was applied to extract k
inact/K
i in data
fitting, providing tremendous flexibility in the experimental design
to characterize covalent inhibitors with various properties. Using
KRASG12C inhibitors as a test case, the platform was demonstrated
to be effective for studying covalent inhibitors with a wide range
of k
inact/K
i values from single digit to 3 × 105 M–1 s–1.